WATERTOWN, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing ...

(MENAFN- GlobeNewsWire - Nasdaq) Wholly-owned laboratory has received CLIA certification from Massachusetts with full license to conduct patient testing and develop companion diagnostics Laboratory ...

Wholly-owned laboratory has received CLIA certification from Massachusetts with full license to conduct patient testing and develop companion diagnostics Laboratory provides significant operational ...

(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the PanTracer™ LBx test has received coverage from the Centers for Medicare & ...

Many people know that finding cancer early, before it spreads, may help increase the chances of treating and surviving cancer.1 But navigating risk factors and getting ahead can ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve chronic disease outcomes for ...

WATERTOWN, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary ...

A Sarasota medical laboratory is cutting a hefty check to the federal government after getting swept up in a Medicare ...

Researchers at Inocras, a bioinformatics-led precision health company harnessing the power of whole-genome sequencing (WGS) ...